SBIO Top Holdings & Constituents
SBIO, offered by SS&C, holds 92 reported positions across $213.1M in assets. Its largest holdings are Kymera Therapeutics Inc (KYMR) (4.66%), Celcuity Inc (CELC) (3.34%), and Alkermes Plc (ALKS) (3.21%). The 5 biggest positions account for 17.33% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
KYMR Kymera Therapeutics Inc | 4.66% | $6.43M |
CELC Celcuity Inc | 3.34% | $4.61M |
ALKS Alkermes Plc | 3.21% | $4.43M |
CGON Cg Oncology Inc | 3.06% | $4.23M |
MIRM Mirum Pharmaceuticals Inc | 3.06% | $4.23M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Feb 28, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.